Compare NGNE & MPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NGNE | MPX |
|---|---|---|
| Founded | 2003 | 1965 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 327.8M | 319.2M |
| IPO Year | N/A | N/A |
| Metric | NGNE | MPX |
|---|---|---|
| Price | $18.30 | $9.38 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $40.14 | N/A |
| AVG Volume (30 Days) | ★ 152.7K | 20.6K |
| Earning Date | 11-13-2025 | 02-06-2026 |
| Dividend Yield | N/A | ★ 5.93% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.38 |
| Revenue | N/A | ★ $227,666,000.00 |
| Revenue This Year | N/A | $3.97 |
| Revenue Next Year | N/A | $13.02 |
| P/E Ratio | ★ N/A | $24.66 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.88 | $7.49 |
| 52 Week High | $37.27 | $10.08 |
| Indicator | NGNE | MPX |
|---|---|---|
| Relative Strength Index (RSI) | 45.81 | 55.19 |
| Support Level | $18.12 | $9.20 |
| Resistance Level | $20.44 | $9.72 |
| Average True Range (ATR) | 1.23 | 0.34 |
| MACD | 0.23 | -0.01 |
| Stochastic Oscillator | 48.61 | 67.69 |
Neurogene Inc is a clinical-stage biotechnology company committed to overcoming the limitations of neurological diseases into treatable conditions, by harnessing its proprietary transgene regulation technology, EXACTTM (Expression Attenuation via Construct Tuning). It is building a differentiated product portfolio of genetic medicines for rare neurological diseases with high unmet needs. The drug candidates in the company's product pipeline include NGN-401, which is in development for the treatment of Rett syndrome, using its EXACT platform, and NGN-101, a non-EXACT, conventional gene therapy development candidate for the treatment of CLN5 Batten disease, designed to deliver the CLN5 gene and packaged in an AAV9 capsid.
Marine Products Corp is a manufacturer of fiberglass motorized boats distributed and marketed through its independent dealer network. The company's only operating segment is Powerboat Manufacturing Business. It operates in the powerboat manufacturing business segment in Nashville, Valdosta, and Georgia. Its product offerings include Chaparral sterndrive, outboard pleasure boats, and Robalo outboard sport fishing boats. The company offers its products to the family recreational markets through its Chaparral brand and to the sportfishing market through its Robalo brand.